Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renato Pascale

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 24, 2020
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre studyMichele Bartoletti, Lorenzo Marconi, Luigia Scudeller, et al.
Jac-Antimicrobial Resistance|March 10, 2022
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing <i>Klebsiella pneumoniae</i>: a multicentre studyMario Tumbarello, Francesca Raffaelli, Antonio Cascio, et al.
Open Forum Infectious Diseases|May 29, 2020
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing <i>Enterobacterales</i> Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)Matteo Bassetti, Antonio Vena, Daniele Roberto Giacobbe, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 12, 2020
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)Michele Bartoletti, Maddalena Giannella, Luigia Scudeller, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 3, 2023
Corrigendum to: "Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)" Clinical Microbiology and Infection 26 (2020) 1545-1553Michele Bartoletti, Maddalena Giannella, Luigia Scudeller, et al.
Open Forum Infectious Diseases|August 9, 2020
Risk Factors for Candidemia After Open Heart Surgery: Results From a Multicenter Case-Control StudyDaniele Roberto Giacobbe, Antonio Salsano, Filippo Del Puente, et al.
The Lancet. Rheumatology|August 25, 2020
Tocilizumab in patients with severe COVID-19: a retrospective cohort studyGiovanni Guaraldi, Marianna Meschiari, Alessandro Cozzi-Lepri, et al.
Open Forum Infectious Diseases|June 10, 2024
Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter StudyMario Tumbarello, Francesca Raffaelli, Maddalena Giannella, et al.
Microorganisms|May 28, 2022
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA CohortMaddalena Giannella, Elda Righi, Renato Pascale, et al.
JAMA Internal Medicine|October 20, 2020
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical TrialCarlo Salvarani, Giovanni Dolci, Marco Massari, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 24, 2020
Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre studyMichele Bartoletti, Lorenzo Marconi, Luigia Scudeller, et al.
Jac-Antimicrobial Resistance|March 10, 2022
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing <i>Klebsiella pneumoniae</i>: a multicentre studyMario Tumbarello, Francesca Raffaelli, Antonio Cascio, et al.
Open Forum Infectious Diseases|May 29, 2020
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing <i>Enterobacterales</i> Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)Matteo Bassetti, Antonio Vena, Daniele Roberto Giacobbe, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 12, 2020
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)Michele Bartoletti, Maddalena Giannella, Luigia Scudeller, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 3, 2023
Corrigendum to: "Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study)" Clinical Microbiology and Infection 26 (2020) 1545-1553Michele Bartoletti, Maddalena Giannella, Luigia Scudeller, et al.
Open Forum Infectious Diseases|August 9, 2020
Risk Factors for Candidemia After Open Heart Surgery: Results From a Multicenter Case-Control StudyDaniele Roberto Giacobbe, Antonio Salsano, Filippo Del Puente, et al.
The Lancet. Rheumatology|August 25, 2020
Tocilizumab in patients with severe COVID-19: a retrospective cohort studyGiovanni Guaraldi, Marianna Meschiari, Alessandro Cozzi-Lepri, et al.
Open Forum Infectious Diseases|June 10, 2024
Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter StudyMario Tumbarello, Francesca Raffaelli, Maddalena Giannella, et al.
Microorganisms|May 28, 2022
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA CohortMaddalena Giannella, Elda Righi, Renato Pascale, et al.
JAMA Internal Medicine|October 20, 2020
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical TrialCarlo Salvarani, Giovanni Dolci, Marco Massari, et al.
Pageof 9